ArticleJournal of Korean medical science2026
Proposal for Modified Alpha Fetoprotein Use in Hepatocellular Carcinoma Surveillance: Analysis of the 2018-2020 National Cancer Screening Program.
Article in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHepatocellular carcinoma (HCC) is a major health concern, highlighting the need for effective surveillance. Republic of Korea's (South Korea's) National Cancer Screening Program (NCSP) uses ultrasound and serum alpha fetoprotein (AFP) tests for high-risk populations, but its performance remains unevaluated. The AFP result is only used when a mass under 1 cm is detected on ultrasound, raising concerns about its appropriateness.
methodsWe analyzed data from 820,380 participants in Korea's NCSP for HCC between 2018 and 2020, comparing the ultrasound-alone protocol, current criteria, and the modified criteria newly proposed in this study. The current criteria define surveillance positivity as positive ultrasound findings or equivocal findings with elevated AFP, while the modified criteria consider either positive ultrasound findings or elevated AFP. Sensitivity, specificity, and area under the receiver operating characteristic (AUROC) curve for detecting HCC with various AFP cutoffs were evaluated.
resultsUltrasound alone had a sensitivity of 44.26% and a specificity of 97.38%. The current criteria achieved a sensitivity of 44.82-46.51% and a specificity of 97.18-97.38% for detecting HCC with various AFP cutoffs ranging from 5 to 100 ng/mL. The AUROC for the modified criteria was 0.8728, significantly higher than that of the current criteria (0.7209,
conclusionThe modified NCSP criteria we proposed, which incorporate AFP more proactively, identified an optimal cutoff for the Korean NCSP by balancing both sensitivity and specificity. This approach may contribute to improving the effectiveness HCC surveillance in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.